Moderna will make a vaccine for both covid and flu by 2023!

Let us know in detail about the booster doses. Are we future-ready to deal with corona? Let us know what experts have to say on this?

Pharmaceutical company Moderna is jointly working on making a COVID-19 and flu booster shot, which could be available in some countries as soon as 2023.

Corona, which is wreaking havoc all over the world, has been intimidating as Omicron since once. However, the vaccination campaign has done a great job of keeping people safe. In this episode, American pharmaceutical company Moderna is trying to achieve another success. Yes, the pharmaceutical company is jointly working on making a covid-19 and flu booster shot, which may be available in some countries as soon as 2023.

The risk of covid-19 infection is not over yet and getting a vaccine to avoid falling ill or going to the hospital can be a good and important decision. It is important to understand that, in difficult times of pandemic, corona and influenza can harm your child's weak body. That is why it becomes very important to give injections to children during epidemics.

The combined vaccine for covid and flu

Given this information, the company's CEO Stefan Bansel said that this vaccine will be available for some countries by next year. Speaking at a virtual event on the Davos Agenda organized by the World Economic Forum this week, the CEO explained that the company has jointly agreed to provide an annual booster shot to avoid the problem of seeking in-place approvals, according to a CNN report. the target has been set.

Actually, people need to take flu shots to avoid flu in winters, but after the arrival of this vaccine, you will have to take only one shot, which will give protection against covid as well as the flu.

Data will be available by March

Meanwhile, The company will have data available on its Omicron-specific COVID-19 vaccine in March.

Steps will be taken soon

In this discussion, there will be a clinical trial of the shot in the coming weeks and will get its data by March, which will be received within the time frame, as expected. We need to be able to get data to share with companies to take the next step forward.

There has always been a great partnership between public health experts, companies, and vaccine producers to figure out what is the best route.

(Disclaimer: The content on this site is for informational purposes only, and should not be taken as professional medical advice. Always seek the guidance of your doctor or other health professionals for any questions you may have regarding your health or a medical condition.)

Tags : #moderna #covidbooster #covid2023 #smitakumar #myhealth #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024